Navigation Links
Biopharm Insight Hosts Educational Webinar Ahead of American Society of Hematology Conference Next Month
Date:11/13/2013

Norwood, MA (PRWEB) November 13, 2013

BioPharm Insight, a division of Infinata, will host an educational webinar to unveil highlights ahead of the American Society of Hematology (ASH) Annual Conference next month. The ASH Conference takes place December 7-10 in New Orleans.

Webinar: BioPharm Insight’s Pre-ASH Crash Course
Speaker: Juliana Wexler, Oncology Reporter
Date & Time: November 21, 10:00 AM EST
Register: http://goo.gl/5ij5j9

The webinar will cover:

  •     Celgene’s Revlimid - MM-020 and MM-015 trial results in newly-diagnosed multiple myeloma (MM)
  •     Array Biopharma’s ARRY-520 Phase Ib results in relapsed/refractory MM
  •     Antibodies in MM, including Genmab/Janssen’s daratumumab
  •     Ambit BioSciences’ quizartinib in AML
  •     MDS update with Array’s ARRY-614, Astex's SGI-110
  •     HDAC inhibitors development for MDS and MM
  •     B-cell inhibitors in CLL -- Gilead’s idelalisib, Pharmacyclics’ ibrutinib, Infinity’s IPI-145

Juliana Wexler specializes in cancer coverage for BioPharm Insight. Previously she was an HIV public health advocate at Jacobi Medical Center in New York, where she was involved in both research and recruiting participants for clinical trials. She has also been a research assistant at both Columbia University, as well as the University of Michigan. Juliana graduated with an individualized Bachelor’s in Health Care and Health Disparities from the University of Michigan.

About BioPharm Insight
BioPharm Insight is part of Infinata, a Financial Times Group company, and a leading provider of business intelligence solutions which also include BioPharm Clinical™, High Net Worth Insight™ and wealthmonitor™. BioPharm Insight provides subscribers with an information edge by combining the most comprehensive real-time database of companies, drugs, contacts, M&A and licensing deals, forecasts and clinical trial data with proprietary forward-looking intelligence uncovered by an independent team of investigative journalists months or even years before it breaks in mainstream media. To learn more, visit http://www.biopharminsight.com.

About Infinata, Inc.
Infinata provides personalized technology solutions to turn information into insight. Services include a comprehensive BioPharm Solutions Suite, unique Wealth Prospecting tools and innovative Custom Data Services. Infinata is a part of Mergermarket, a Financial Times Group company and a division of Pearson plc. To learn more, visit http://www.infinata.com.

Business Inquiries: Holly Burke, hburke[at]infinata[dot]com, 781-619-0131
Media Inquiries: Brenda Nashawaty, Brenda[at]nashawaty[dot]com, 617-688-3253

Read the full story at http://www.prweb.com/releases/2013/11/prweb11325293.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Biopharmaceuticals - A Global Market Overview
2. Biopharm Insight’s Respiratory Disease Report Highlights Key Drugs Coming Up for Approval or in Late-Stage Development
3. Mass Spectrometry Marketplace Discussed by Biopharm Reports in In-demand Research Study Available at MarketPublishers.com
4. World Antibiotic Resistance Market Saw Big Changes in Last Five Years, According to Biopharm Reports Study Available at MarketPublishers.com
5. Therapure Biopharma Inc. Awarded US Government Contract for Development of Anti-Nerve Gas Agent
6. Monoclonal Antibodies Market Dealmaking in Biopharma Industry Analyzed in New Research Report at ReportsnReports.com
7. BioPharm Systems Unveils Study Data Mapper to Simplify the Preparation and Reporting of Clinical Data
8. Nine Lives Media Names BioPharm Systems to the MSPmentor 501
9. BioPharm Systems to Host Webinar on Clinical Trial Supply Management with Siebel CTMS
10. BioPharm Systems to Host Webinar on Using iHelp in Oracle’s Siebel Clinical Trial Management System
11. BioPharm Systems Named to the 2012 Lead411 Technology 200 List
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2019)... ... August 21, 2019 , ... An August 1st article on CTV ... of going abroad for cheap plastic surgery. The article followed several women who chose ... fraction of what they would have paid in their native Canada. They returned with ...
(Date:8/21/2019)... ... August 21, 2019 , ... Never Bean ... Pennsylvania, a lovable, socially popular, registered therapy dog, television actor, and canine ... Better Day. The Registrar at National Day Calendar has declared Never Bean Better ...
(Date:8/21/2019)... ... August 21, 2019 , ... ... technology: HDRX imaging. HDRX captures extremely high-resolution images of products for superior ... high image resolution at normal production line speeds within power settings used ...
(Date:8/19/2019)... (PRWEB) , ... August 19, 2019 , ... ... platform selling Eminence Organic Skin Care products , the authorized retailer will ... Darlene DeVries, was a practicing esthetician in Florida providing Eminence Organic Skin Care ...
(Date:8/19/2019)... ... August 19, 2019 , ... Professional Enrollment Concepts (PEC), ... proudly announces they have ranked #3056 on the 2019 Inc. 5000 Fastest-Growing Private ... look at the most successful companies within the American economy's most dynamic segment—its ...
Breaking Medicine News(10 mins):
(Date:8/23/2019)... Ill. (PRWEB) , ... August ... ... University Edwardsville online master’s in healthcare informatics has been ranked sixth in ... professionals integrate the worlds of medicine and technology by combining their expertise ...
(Date:8/21/2019)... , ... August 21, 2019 , ... Dr. Parsa Mohebi, ... and Beverly Hills, recently opened his newest medical office in the city of San ... in the San Francisco area along with the surrounding cities of Oakland, San Jose, ...
(Date:8/21/2019)... ... August 21, 2019 , ... Impact Advisors , a ... announced today that it has been named to Inc. magazine’s Inc. 5000 list. The ... for-profit companies with significant percentage revenue growth. This year the firm was also named ...
Breaking Medicine Technology: